<DOC>
	<DOCNO>NCT00516399</DOCNO>
	<brief_summary>The purpose study determine effectiveness 1.25 % povidone-iodine ophthalmic solution treatment small medium size fungal corneal ulcer compare antifungal antibiotic .</brief_summary>
	<brief_title>A Clinical Trial Treatment Fungal Corneal Ulcers With Povidone-Iodine</brief_title>
	<detailed_description>The medication study 1.25 % povidone-iodine solution control medication 5 % natamycin ophthalmic suspension . The povidone-iodine concentration 1.25 % chosen base study use povidone-iodine ophthalmic solution first week ocular surgery . Initially , patient complain sting sensation use 2.5 % concentration . This might prevent full compliance subject . When solution dilute 1.25 % , complaint discomfort . Therefore , actual one-week postoperative clinical trial , 1.25 % concentration use without patient complaint find effective . In pilot study conduct Philippines , investigate treatment small medium-sized fungal corneal ulcer , 1.25 % povidone-iodine show effective fungal corneal ulcer include cause Fusarium solani Mycelia sterila treat 7-20 day . The povidone-iodine 1.25 % solution prepare remove 1.875 ml . solution 15 ml . bottle Balanced Salt Solution ( BSS ) , ( Alcon Laboratories , Inc. , Fort Worth ) insert 1.875 ml . 10 % povidone-iodine solution ( Betadine solution , Purdue Frederick , Norwalk ) . Preparations make weekly subject use sterile technique store cool dark place . The control anti-fungal natamycin ophthalmic suspension , USP 5 % ( Natamet , M.J. Pharmaceuticals Ltd. , Mumbai , India ) , represent current standard care . The subject discharge home randomize medication assign hospitalize . Prospective candidate study , and/or parent guardian , review appropriate Human Subjects Consent Form , approve Human Subjects Protection Committee Harbor-UCLA Medical Center . After write consent , Informed HIPPA , obtain , subject randomize receive either povidone-iodine control drug . All subject hospitalize minimum duration 7 day careful monitoring appropriate treatment . To assure compliance , inpatient subject medication administer medical personnel . Upon admission , intake clinical examination record . Each infected eye randomly assign research nurse treat povidone-iodine 1.25 % control , anti-fungal medication natamycin . Randomization achieve use random number generate randomization schedule . To guarantee similar distribution occur , leave chance , study site randomization schedule stratify ulcer size &lt; 3mm . &gt; 3mm . The eye medication permit beside povidone-iodine 1.25 % ophthalmic solution control drug natamycin , atropine ophthalmic solution reduce intraocular inflammation prevent synechiae , anti-glaucoma medication need . The atropine administer affected eye ( ) twice day strength vary accord subject 's age . Subjects less 1 year age give atropine 0.25 % , age 1-3 give 0.5 % , subject great 3 year age give 1 % . The dose schedule povidone-iodine 1.25 % control medication follow : 1 . For first three day , one drop medication apply every hour . 2 . Day 4 thereafter , hourly awake , asleep , every three hour . Sleep exceed 9 hour . Treat case intense drop therapy minimum 5 day unless criterion change therapy met . 3 . At 5 day , decrease dosing frequency every 2 hour awake `` cured '' , deterioration factor improve least one factor , epithelial defect , note 2 consecutive examination . 4 . If 10 day status remain unchanged , subject exit study . 5 . After discharge , dose frequency remain every 2 hour awake cure .</detailed_description>
	<mesh_term>Keratitis</mesh_term>
	<mesh_term>Corneal Ulcer</mesh_term>
	<mesh_term>Povidone-Iodine</mesh_term>
	<mesh_term>Iodine</mesh_term>
	<mesh_term>Cadexomer iodine</mesh_term>
	<mesh_term>Natamycin</mesh_term>
	<mesh_term>Povidone</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>1 . Be 1 month old . 2 . Have history culture positive fungal corneal ulcer , begin within 14 day presentation study center characterize either stromal defect infiltrate exudate , positive fungal stain smear . Other clinical criterion suspect fungal ulcer include firm ( sometimes dry ) elevate slough , `` hyphate '' line extend beyond ulcer edge normal cornea , endothelial plaque , history organic material strike eye , intense inflammation cornea anterior chamber , immune ring , Descemet 's fold , multifocal granular ( feathery ) greywhite satellite stromal infiltrates . A hypopyon may present . The diameter ulcer 1 mm 6 mm , long scleral involvement . 3 . It acceptable enroll subject receive graft , provide graft meet follow requirement : 1 . The central ulcer well within donor cornea . 2 . There suture abscess . 3 . The graft previously fail . 4 . The subject foreign body present cornea eye . A subject enrol foreign body totally remove enrollment criterion meet . 1 . The initial culture fail show presence fungi . 2 . The patient history allergy povidoneiodine , iodine , natamycin . 3 . The cornea sclera perforate perforation impend . 4 . The unaffected eye legally blind . 5 . Dacrocystitis present . 6 . Neurotrophic keratitis , exposure keratitis keratitis sicca present . 7 . Prescribed topical systemic steroid immunosuppressant use , unless discontinue randomization . 8 . The patient know HIV positive . 9 . The infiltrate extends posterior onethird stroma . 10 . The initial culture show significant growth bacteria ( &gt; 10 colony ) . 11 . Any topical antifungal agent use within past week . 12 . Both eye infect .</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Fungal keratitis</keyword>
	<keyword>povidone iodine</keyword>
	<keyword>childhood blindness</keyword>
	<keyword>povidone-iodine</keyword>
</DOC>